8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Meet Veristat at the Gene Therapy for Rare Disorders Conference 2022 in Boston, MA - March 7-10, 2022 at Booth 22
Veristat will be exhibiting and presenting at the 2022 Gene Therapy for Rare Disorders Conference. Our teams have worked on 110+ cell and gene therapy projects in the past 5 years - over 70% of them in rare disorders. No matter your need, our scientific experts are adept at both strategy and execution across the clinical development journey.
Schedule a meeting using the form and attend our presentation, Operational Challenges of Natural History Trials to learn more.
Attend Our Presentation
Title: Operational Challenges of Natural History Trials
Date & Time: March 8, 2022 at 2:30 PM ET
Hear Veristat experts discuss operational challenges of natural history trials for gene therapies, including:
- Pivoting to a virtual and in-person hybrid trial model to benefit patients and sponsors alike during COVID-19
- Operationalization of a novel clinical trial design
- Case study examples of overcoming operational challenges for retrospective and prospective data collection in a pediatric, rare-disease population
Kara Langer Kim MacDonnell, BScN, MSc, RN, CGC
Senior Project Manager Lead Clinical Research Associate
Schedule A Meeting
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Conference Details
Website: https://genetherapy-conference.com/